• Tue, March 11, 2014
  • Mon, March 10, 2014
  • Fri, March 14, 2014
  • Wed, March 12, 2014
  • Mon, March 17, 2014
  • Wed, March 19, 2014
  • Thu, March 20, 2014
  • Tue, March 18, 2014
  • Fri, March 21, 2014
  • Tue, March 25, 2014
  • Mon, March 24, 2014

Andrew Fein Initiated (BCRX) at Strong Buy and Held Target at $21 on, Mar 10th, 2014

Andrew Fein of HC Wainwright & Co., Initiated "BioCryst Pharmaceuticals, Inc." (BCRX) at Strong Buy and Held Target at $21 on, Mar 10th, 2014.

Andrew has made no other calls on BCRX in the last 4 months.



There are 2 other peers that have a rating on BCRX. Out of the 2 peers that are also analyzing BCRX, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Justin Kim of "Oppenheimer" Initiated at Hold on, Thursday, February 27th, 2014


This is the rating of the analyst that currently disagrees with Andrew


  • Tazeen Ahmad of "B of A Securities" Downgraded from Hold to Sell on, Tuesday, January 28th, 2014

Like: 👍